BioCryst Reports Second Quarter 2017 Financial Results

Go back to BioCryst Reports Second Quarter 2017 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.68 --0 (-0%)
Previous Close $8.68    52 Week High $10.98 
Open $8.68    52 Week Low $1.63 
Day High $8.68    P/E N/A 
Day Low $8.68    EPS $-0.68 
Volume 3,274